
Xtant Medical Holdings XTNT
$ 0.73
4.33%
Quarterly report 2025-Q3
added 11-10-2025
Xtant Medical Holdings Interest Expense 2011-2025 | XTNT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Xtant Medical Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.16 M | 2.94 M | 1.69 M | 995 K | 5.98 M | 5.77 M | 10.1 M | 14.7 M | 12.3 M | 7.73 M | 5.66 M | 4.65 M | 1.86 M | 1.16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.7 M | 995 K | 5.69 M |
Quarterly Interest Expense Xtant Medical Holdings
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16 K | 1 M | - | -13 K | 992 K | 835 K | - | 760 K | 786 K | 575 K | - | 440 K | 397 K | 359 K | - | 329 K | 199 K | 1 K | - | 2.1 M | 2.05 M | 1.11 M | - | 1.18 M | 1.3 M | 2.02 M | - | 1.79 M | 2.82 M | 3.54 M | - | 3.81 M | 3.33 M | 3.4 M | - | 3.16 M | 2.98 M | 2.83 M | - | 2.11 M | 1.38 M | 1.44 M | - | 1.5 M | 1.44 M | 1.28 M | - | 1.2 M | 1.17 M | 1.06 M | - | 868 K | 266 K | 171 K | - | 541 K | 133 K | 372 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.81 M | -16 K | 1.34 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.86 | -3.26 % | $ 134 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 307.92 | -1.93 % | $ 8.69 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 45.13 | -2.67 % | $ 6.72 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.1 | 1.48 % | $ 218 B | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 92.34 | 0.64 % | $ 136 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 2.56 | 8.94 % | $ 95.5 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.7 | -3.46 % | $ 408 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.88 | 0.05 % | $ 709 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 165.15 | 0.78 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 1.07 | -3.18 % | $ 110 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 12.81 | -1.23 % | $ 346 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.86 | -0.03 % | $ 97.4 M | ||
|
AxoGen
AXGN
|
-199 K | $ 30.33 | 1.15 % | $ 1.34 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.78 | 2.33 % | $ 1.26 B | ||
|
Globus Medical
GMED
|
2.2 M | $ 86.83 | -2.31 % | $ 11.8 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 13.41 | -4.56 % | $ 1.03 B | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 20.04 | 0.65 % | $ 2.86 B | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 3.4 | - | $ 5.31 M | ||
|
Establishment Labs Holdings
ESTA
|
-15.3 M | $ 72.58 | -0.19 % | $ 2.04 B | ||
|
Electromed
ELMD
|
78 K | $ 29.74 | 0.64 % | $ 251 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 96.35 | -1.06 % | $ 1.22 B |